The multifunctional nanoparticles Wang et al. designed can achieve targeted delivery of HuR CRISPR and epirubicin, and significantly improved the symptoms of mice bearing SAS tumors Wang et al. (2021a). This evidence concerns the gene ELAVL1 and SATB2 associated disorder.